After decades of controversy over prescribing hormone therapy for perimenopause, many providers are reconsidering their approach.

A new Scientific Statement released today by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improvements in overall health and reducing the risk of co...

Phthalates, which are chemicals found in plastics, personal care products and hundreds of other consumer goods, may contribute to high blood pressure in pregnant women, according to a study published ...

Published: July 28, 2026

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.

A new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical care.

GLP-1 medications could help male patients improve their testosterone levels and their fertility, a new study has found. The research determined that men ages 18-65 who participated in the study showe...

Not only are GLP-1 medications likely not harmful to male fertility, but they may help improve testosterone levels, sperm health and production, study says.

New research shows that people are more likely to drop and pick back up GLP-1 drugs than previously thought About 6 in 10 quit taking them after two years, researchers found, but nearly two-thirds res...

CHICAGO — In postmenopausal women, use of menopausal hormone therapy was associated with higher bone mineral density compared with nonuse, according to a study presented at ENDO 2026. “We undertook th...

Findings suggest young females should be assessed and, if at risk, monitored.

People's daily steps might drop after starting a GLP-1 prescription, new research suggests.

New data from ENDO 2026 have indicated a statistically significant increase in hypotension and related events in adults receiving GLP-1s who are already hypertensive.

'Children are entering puberty younger than in past decades,' guideline panel co-chair says

Some subgroups of children with precocious puberty—such as older girls with slowly progressing puberty—may not need the same level of testing or treatment, according to a new Endocrine Society Clinica...

People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal ...

The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Sh...

As deaths from diabetes start to rival those from infectious threats like malaria, a new form of the condition linked to malnutrition is surfacing in patients who can afford neither screening nor care.

Chemicals called PFAS may lower bone density in adolescents, a new study has found.

A mouse study found that a father’s nicotine exposure can affect the offspring’s ability to process sugar and may contribute to diabetes risk, according to new research published in the Journal of the...

Members of the media can now register to cover advances in hormone health and science at ENDO 2026, the Endocrine Society’s annual meeting. The meeting will take place June 13-16, in Chicago, Ill.

The Society works to reduce prevalence of obesity. Explore our statements, guidelines, resources, and more.

TUESDAY, Feb. 3, 2026 (HealthDay News) — Middle-aged women with elevated insulin levels might be in for a tougher menopause experience, a new study says.Women w

"What is good for the heart is good for the brain," one researcher says.

European researchers trace a path that shows how high blood pressure caused by excess weight could be the link to certain cognitive brain disease.

Answer: Probably not. Here's what to know.

New drug candidates could transform the obesity treatment landscape again, as pill formulations and multi-agonist treatments undergo clinical trials. Endocrine Society experts Priya Jaisinghani, MD, DABOM, and Mehmet Furkan Burak, MD, discussed how emerging treatments could improve obesity treatment and provide new options for patients. Access additional obesity resources: https://bit.ly/3yV6Ihc Eli Lilly and Company provided support for this event.

New drug candidates could transform the obesity treatment landscape again, as pill formulations and multi-agonist treatments undergo clinical trials. Endocrine Society experts Priya Jaisinghani, MD, DABOM, and Mehmet Furkan Burak, MD, discussed how emerging treatments could improve obesity treatment and provide new options for patients. Access additional obesity resources: https://bit.ly/3yV6Ihc Eli Lilly and Company provided support for this event.

A large body of science has linked phthalates to a variety of serious health conditions, including premature birth and infertility.

In an interview with CBS News, FDA Commissioner Dr. Marty Makary explains what went into the decision to drop the most serious warnings on hormone therapy for menopause.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

Studies combing through past patient data have made a similar link between drugs like Ozempic and a loss of appetite for more than just food.

The hormone oxytocin may shield women from mood disturbances when they face sleep disruptions in the postpartum transition or during menopause. Irene Gonsalvez, MD, describes the research she presented at ENDO 2025. “The higher the oxytocin levels the night before the sleep disruption was co-related with better mood the day after. The study results suggest that oxytocin may play a protective role and can help these women to lessen the adverse effects of estradiol suppression and sleep interruption that they have in their mood state.”— Irene Gonsalvez, MD

People with excess body fat who build and keep muscle may be less likely to develop obesity-induced heart, liver, or kidney damage or die early, according to a new study published in The Journal of Cl...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine Socie...

Medications that prevent HIV, shrink tumors and treat seizures were invented with government funding. At research universities, that money is now canceled or in jeopardy.